Free Trial

Sanofi (SNY) Earnings Date, Estimates & Call Transcripts

$48.54
-0.46 (-0.94%)
(As of 05/24/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jul. 26Estimated
Actual EPS
(Apr. 25)
$0.96
Consensus EPS
(Apr. 25)
$0.96
Skip Charts & View Estimated and Actual Earnings Data

SNY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SNY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sanofi Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.94$1.14$1.02 
Q2 20243$0.90$1.05$0.96 
Q3 20243$1.30$1.64$1.44 
Q4 20243$0.81$1.18$0.95 
FY 202412$3.95$5.01$4.38 
Q1 20251$1.09$1.09$1.09 
Q2 20251$0.98$0.98$0.98 
Q3 20251$1.27$1.27$1.27 
Q4 20251$1.17$1.17$1.17 
FY 20254$4.51$4.51$4.51 
Q1 20261$1.37$1.37$1.37 

SNY Earnings Date and Information

Sanofi last announced its quarterly earnings data on April 25th, 2024. The reported $0.96 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.96. The company earned $11.36 billion during the quarter, compared to analysts' expectations of $11.75 billion. Sanofi has generated $1.99 earnings per share over the last year ($1.99 diluted earnings per share) and currently has a price-to-earnings ratio of 24.4. Earnings for Sanofi are expected to grow by 13.35% in the coming year, from $4.12 to $4.67 per share. Sanofi has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off prior year's report dates.

Sanofi Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/26/2024
(Estimated)
------- 
4/25/2024Q1 2024$0.96$0.96-$1.43$11.75 billion$11.36 billion
2/1/2024Q4 2023$0.94$0.89($0.05)$2.02$13.02 billion$11.76 billion
10/27/2023Q3 2023$1.37$1.39+$0.02$1.67$13.61 billion$13.02 billion
7/28/2023Q2 2023$0.88$0.95+$0.07$1.27$11.47 billion$10.85 billion
7/28/2023Q2 2023$0.88$0.95+$0.07$1.27$11.47 billion$10.85 billion    
4/27/2023Q1 2023$1.10$1.16+$0.06$1.46$11.60 billion$10.97 billion
4/27/2023Q1 2023$1.10$1.16+$0.06$1.46$11.60 billion$10.97 billion    
2/3/2023Q4 2022$0.90$0.87($0.03)$1.15$11.51 billion$10.95 billion
2/3/2023Q4 2022$0.90$0.87($0.03)$1.15$11.51 billion$10.95 billion
10/28/2022Q3 2022$1.32$1.45+$0.13$2.06$12.05 billion$12.58 billion
10/28/2022Q3 2022$1.32$1.45+$0.13$2.06$12.05 billion$12.58 billion
7/28/2022Q2 2022$0.85$0.92+$0.07$1.34$10.32 billion$10.78 billion
7/28/2022Q2 2022$0.85$0.92+$0.07$1.34$10.32 billion$10.78 billion
4/28/2022Q1 2022$0.94$1.09+$0.15$1.28$10.33 billion$10.85 billion
4/28/2022Q1 2022$0.94$1.09+$0.15$1.28$10.33 billion$10.85 billion
4/28/2022Q1 2022$0.94$1.09+$0.15$1.28$10.33 billion$10.85 billion
2/4/2022Q4 2021$0.76$0.79+$0.03$1.06$11.78 billion$11.43 billion
2/4/2022Q4 2021$0.76$0.79+$0.03$1.06$11.78 billion$11.43 billion
2/4/2022Q4 2021$0.76$0.79+$0.03$1.06$11.78 billion$11.43 billion
10/28/2021Q3 2021$1.18$1.29+$0.11$1.49$12.49 billion$12.30 billion
10/28/2021Q3 2021$1.18$1.29+$0.11$1.49$12.49 billion$12.30 billion
10/28/2021Q3 2021$1.18$1.29+$0.11$1.49$12.49 billion$12.30 billion
7/29/2021Q2 2021$0.79$0.83+$0.04$1.08$10.29 billion$10.53 billion
7/29/2021Q2 2021$0.79$0.83+$0.04$1.08$10.29 billion$10.53 billion
7/29/2021Q2 2021$0.79$0.83+$0.04$1.08$10.29 billion$10.53 billion    
4/28/2021Q1 2021$0.83$0.97+$0.14$1.19$10.37 billion$10.36 billion
4/28/2021Q1 2021$0.83$0.97+$0.14$1.19$10.37 billion$10.36 billion
4/28/2021Q1 2021$0.83$0.97+$0.14$1.19$8.48 billion$8.59 billion  
2/5/2021Q4 2020$0.88$0.73($0.15)$0.95$11.71 billion$11.19 billion
2/5/2021Q4 2020$0.88$0.73($0.15)$0.95$11.71 billion$11.19 billion
2/4/2021Q4 2020$0.88$0.73($0.15)$0.95$9.39 billion$9.38 billion  
10/29/2020Q3 2020$1.08$1.07($0.01)$1.23$11.82 billion$11.08 billion
10/29/2020Q3 2020$1.08$1.07($0.01)$1.23$11.82 billion$11.08 billion
10/29/2020Q3 2020$1.08$1.07($0.01)$1.23$11.82 billion$11.08 billion
10/29/2020Q3 2020$1.09$1.07($0.02)$1.23$9.65 billion$9.48 billion  
7/29/2020Q2 2020$0.70$0.65($0.05)$0.60$9.94 billion$9.04 billion
7/29/2020Q2 2020$0.70$0.65($0.05)$0.60$9.94 billion$9.04 billion
7/29/2020Q2 2020$0.70$0.65($0.05)$0.60$9.94 billion$9.04 billion
7/29/2020Q2 2020$0.70$0.65($0.05)$0.60$9.94 billion$9.04 billion
4/24/2020Q1 2020$0.76$0.90+$0.14$1.06$9.64 billion$9.90 billion
A personal note from Behind The Markets' CEO Dylan Jovine... (Ad)

Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! If you want to see just how much your mystery discount is...

You can UNCOVER YOUR MYSTERY DISCOUNT HERE!
4/24/2020Q1 2020$0.76$0.90+$0.14$1.06$9.64 billion$9.90 billion
4/24/2020Q1 2020$0.76$0.90+$0.14$1.06$9.64 billion$9.90 billion
4/24/2020Q1 2020$0.76$0.90+$0.14$1.06$9.64 billion$9.90 billion
2/6/2020Q4 2019$0.70$0.74+$0.04$1.49$11.12 billion$10.64 billion
2/6/2020Q4 2019$0.70$0.74+$0.04$1.49$11.12 billion$10.64 billion
2/6/2020Q4 2019$0.70$0.74+$0.04$1.49$11.12 billion$10.64 billion
2/6/2020Q4 2019$0.70$0.74+$0.04$1.49$11.12 billion$10.64 billion
10/31/2019Q3 2019$0.96$1.07+$0.11$1.31$10.62 billion$10.56 billion
10/31/2019Q3 2019$0.96$1.07+$0.11$1.31$10.62 billion$10.56 billion
10/31/2019Q3 2019$0.96$1.07+$0.11$1.31$10.62 billion$10.56 billion
10/31/2019Q3 2019$0.96$1.07+$0.11$1.31$10.62 billion$10.56 billion
7/29/2019Q2 2019$0.67$0.74+$0.07$1.52$9.88 billion$9.70 billion
7/29/2019Q2 2019$0.67$0.74+$0.07$1.52$9.88 billion$9.70 billion
7/29/2019Q2 2019$0.67$0.74+$0.07$1.52$9.88 billion$9.70 billion
7/29/2019Q2 2019$0.67$0.74+$0.07$1.52$8.42 billion$8.63 billion  

Sanofi Earnings - Frequently Asked Questions

When is Sanofi's earnings date?

Sanofi has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off last year's report dates. Learn more on SNY's earnings history.

Did Sanofi beat their earnings estimates last quarter?

In the previous quarter, Sanofi (NASDAQ:SNY) reported $0.96 earnings per share (EPS) to hit the analysts' consensus estimate of $0.96. Learn more on analysts' earnings estimate vs. SNY's actual earnings.

How much revenue does Sanofi generate each year?

Sanofi (NASDAQ:SNY) has a recorded annual revenue of $46.61 billion.

How much profit does Sanofi generate each year?

Sanofi (NASDAQ:SNY) has a recorded net income of $5.84 billion. SNY has generated $1.99 earnings per share over the last four quarters.

What is Sanofi's price-to-earnings ratio?

Sanofi (NASDAQ:SNY) has a trailing price-to-earnings ratio of 24.39 and a forward price-to-earnings ratio of 11.78. The price/earnings-to-growth ratio is 1.57.

What is Sanofi's EPS forecast for next year?

Sanofi's earnings are expected to grow from $4.12 per share to $4.67 per share in the next year, which is a 13.35% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:SNY) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners